1-(3-Chloropyridin-2-yl)-4-ethylpiperazine

Catalog No. :
ACZTYO128
CAS No. :
1280786-84-6
Molecular Formula :
C11H16ClN3
Molecular Weight :
225.72

IUPAC Name:1-(3-chloropyridin-2-yl)-4-ethylpiperazine

1-(3-Chloropyridin-2-yl)-4-ethylpiperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$136.00Login to see priceInquiryInquiry
25g95%$369.00Login to see priceInquiryInquiry
100g95%$952.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Chloropyridin-2-yl)-4-ethylpiperazine
IUPAC Name1-(3-chloropyridin-2-yl)-4-ethylpiperazine
MDL No.MFCD18783196
Molecular FormulaC11H16ClN3
Molecular Weight225.72
SMILESCCN1CCN(C2=NC=CC=C2Cl)CC1
InChI KeyPQNPCCOIXGMFSP-UHFFFAOYSA-N
Synonym1280786-84-6 | 1-(3-Chloropyridin-2-yl)-4-ethylpiperazine | 3-Chloro-2-(4-ethylpiperazino)pyridine | DTXSID60682482 | MFCD18783196 | AKOS015892197 | BS-20580 | Piperazine, 1-(3-chloro-2-pyridinyl)-4-ethyl- | A889070
CAS No.1280786-84-6
PubChem CID53217443

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZTYO128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGROW947 route compound structure diagram
    ACGROW94787394-55-6 In Stock
  4. Then
  5. ACZTYO128 route product structure diagram
    ACZTYO1281280786-84-6
Inquiry

2. ACZTYO128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZTYO128 route product structure diagram
    ACZTYO1281280786-84-6
Inquiry

Comments (0)